Silence Therapeutics (STU:XRP2) Net Interest Margin (Bank Only) %


STU:XRP2 Silence Therapeutics PLC STU:XRP2
50 GF Score
Price €8.00
GF Value €0.11
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Silence Therapeutics Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

STU:XRP2
50GF Score
Silence Therapeutics PLC STU:XRP2
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Silence Therapeutics (STU:XRP2) Overvalued in 2026?

Based on GuruFocus' analysis, Silence Therapeutics stock appears to be overvalued. The current stock price of €8.00 is trading 7172.7% above its estimated GF Value™ of €0.11. GuruFocus considers Silence Therapeutics to be Significantly Overvalued.

Key valuation signals for STU:XRP2:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €0.11 vs. price of €8.00 (7172.7% above fair value)
  • GF Score™: 50/100 with 5 warning signs

No single metric tells the full story. See the STU:XRP2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Silence Therapeutics Business Description

Other Exchanges SLN:USASLNCF:USA
Address 12 Hammersmith Grove, London, GBR, W6 7AP
Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for its internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.
50GF Score

Get the complete analysis for STU:XRP2

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.00
Price
€0.11
GF Value